Maziar Assadi Gehr

Maziar Assadi Gehr, MD, has extensive work experience in the medical field. Maziar served as the Medical Director Anti-Infectives at Basilea Pharmaceutica, where they provided medical leadership for various programs and had interactions with regulatory authorities. Maziar also accomplished compiling and submitting an NDA, publishing clinical trial results, and initiating collaborations with research centers. Prior to that, they worked as a Global Medical Affairs Physician at Actelion, leading clinical studies in pulmonary arterial hypertension and serving as a member of the Life Cycle Team for a product treating cutaneous T-cell lymphoma. Their earlier experience includes roles at Roche, where they served as a Medical Manager and a Senior Scientist, leading the development of biomarker assays and conducting research experiments using proteomics technologies. Maziar also collaborated with esteemed professors and published their findings. Maziar began their career as a Post-doc at the University of Zurich, conducting research in muscular dystrophies, and later served as an Assistant, involved in teaching and investigating protection mechanisms in Duchenne muscular dystrophy. Maziar gained clinical experience as a Resident at the University Hospital of Zurich and the University Hospital of Bern, where they also worked as a Scientific employee.

Maziar Assadi Gehr, MD attended Academic high school in Sursee, Switzerland from 1985 to 1992. Maziar then pursued their MD degree in Medicine at the University of Basel from 1992 to 1998. Following that, Maziar Assadi Gehr completed postgraduate training in Experimental Medicine at the University of Zurich, Roche Center for Medical Genomics from 2003 to 2005. Finally, they focused on Pharmaceutical Medicine at ECPM, University of Basel from 2011 to 2013.